Lyka Labs Ltd (LYKALABS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 189121, "name": "Lyka Labs", "stock_name": "Lyka Labs", "full_name": "Lyka Labs Ltd", "name_url": "stocks-analysis/lyka-labs", "exchange": 0, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "69.95", "chg": -3.05, "chgp": "-4.18%", "dir": -1, "prev_price": "73.00", "mcapval": "252.00 Cr", "mcap": "Micro Cap", "scripcode": 500259, "symbol": "LYKALABS", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE933A01014", "curr_date": "Feb 03", "curr_time": "", "bse_nse_vol": "94.46 k", "exc_status": "Active", "traded_date": "Feb 03, 2026", "traded_date_str": "2026 02 03", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lyka-labs-189121-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Lyka Labs Ltd Stock Falls to 52-Week Low of Rs.70 Amidst Continued Downtrend", "link": "https://www.marketsmojo.com/news/stocks-in-action/lyka-labs-ltd-stock-falls-to-52-week-low-of-rs70-amidst-continued-downtrend-3816418", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LykaLabsLtd_priceRelatedfactors_3816418.png", "date": "2026-02-02 11:10:49", "description": "Lyka Labs Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.70 today, marking a significant decline in its stock price amid ongoing market pressures and company-specific challenges." }, { "title": "Lyka Labs Declines 1.61% This Week: 2 Key Events Impact Share Price", "link": "https://www.marketsmojo.com/news/stocks-in-action/lyka-labs-declines-161-this-week-2-key-events-impact-share-price-3814711", "imagepath": "", "date": "2026-02-01 14:00:08", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Jan 27:</strong> Stock rises 1.63% to Rs.73.78 on moderate volume</p>\n <p><strong>Jan 28:</strong> Further gains of 2.18% to Rs.75.39 amid positive market momentum</p>\n <p><strong>Jan 29:</strong> Sharp decline of 3.74% to Rs.72.57 following Q2 FY26 results revealing sharp losses</p>\n <p><strong>Jan 30:</strong> Stock hits 52-week low at Rs.71.25, closing at Rs.71.43 (-1.57%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.72.60</div></div>\n <div class=\"stat-item\"><div class=\"sta..." }, { "title": "Lyka Labs Ltd Valuation Shifts Signal Heightened Risk Amidst Market Underperformance", "link": "https://www.marketsmojo.com/news/stocks-in-action/lyka-labs-ltd-valuation-shifts-signal-heightened-risk-amidst-market-underperformance-3813527", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LykaLabsLtd_valuationdot_3813527.png", "date": "2026-02-01 08:00:41", "description": "Lyka Labs Ltd has experienced a marked deterioration in its valuation parameters, shifting from fair to risky territory, as reflected in its sharply negative price-to-earnings (P/E) ratio and elevated price-to-book value (P/BV). This shift underscores growing investor concerns amid subdued financial performance and sector headwinds, prompting a downgrade to a Strong Sell rating by MarketsMOJO." }, { "title": "Lyka Labs Ltd Downgraded to Strong Sell as Quality Parameters Deteriorate", "link": "https://www.marketsmojo.com/news/stocks-in-action/lyka-labs-ltd-downgraded-to-strong-sell-as-quality-parameters-deteriorate-3813472", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LykaLabsLtd_qualitydot_3813472.png", "date": "2026-02-01 08:00:14", "description": "Lyka Labs Ltd has seen a marked decline in its quality grading, slipping from an average to a below average rating as of 12 January 2026. This downgrade reflects deteriorating business fundamentals, including weakening profitability metrics, elevated debt levels, and inconsistent operational performance, raising concerns for investors amid a challenging market backdrop." }, { "title": "Are Lyka Labs Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-lyka-labs-ltd-latest-results-good-or-bad-3811840", "imagepath": "", "date": "2026-01-30 19:18:04", "description": "Lyka Labs Ltd's latest financial results for Q2 FY26 reveal significant operational challenges. The company reported a net loss of ₹3.36 crores, a stark contrast to the profit of ₹0.93 crores in the previous quarter, indicating a troubling shift in profitability. Revenue for the quarter was ₹36.66 crores, reflecting a sequential increase of 10.99% from ₹33.03 crores in Q1 FY26, but this was accompanied by a year-on-year decline of 10.93% from ₹41.16 crores in Q2 FY25.\n\nThe operating margin, which excludes other income, fell dramatically to -6.93%, down from 11.17% in the prior quarter. This substantial decline in margins suggests that the company is facing severe cost pressures, particularly with employee costs rising significantly, which have outpaced revenue growth. The profit before tax also turned negative, highlighting a critical profitability crisis.\n\nIn terms of return metrics, the latest return on e..." }, { "title": "Lyka Labs Ltd Stock Hits 52-Week Low Amid Continued Downtrend", "link": "https://www.marketsmojo.com/news/stocks-in-action/lyka-labs-ltd-stock-hits-52-week-low-amid-continued-downtrend-3811530", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LykaLabsLtd_priceRelatedfactors_3811530.png", "date": "2026-01-30 12:45:06", "description": "Lyka Labs Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a fresh 52-week low of Rs.71.25 today, marking a significant decline amid ongoing downward momentum. The stock has underperformed its sector and broader market indices, reflecting persistent pressures on its valuation and financial metrics." }, { "title": "Lyka Labs Q2 FY26: Sharp Losses Trigger Alarm as Operational Collapse Deepens", "link": "https://www.marketsmojo.com/news/result-analysis/lyka-labs-q2-fy26-sharp-losses-trigger-alarm-as-operational-collapse-deepens-3810163", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LykaLabs_quaterlyResult_3810163.png", "date": "2026-01-29 19:15:44", "description": "Lyka Labs Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹264.00 crores, has plunged into severe operational distress in Q2 FY26, reporting a consolidated net loss of ₹3.36 crores compared to a profit of ₹0.93 crores in the previous quarter—a staggering decline of 461.29% quarter-on-quarter. Year-on-year, the loss represents a catastrophic 260.00% deterioration from the ₹2.10 crores profit reported in Q2 FY25. The stock has responded brutally to the company's deteriorating fundamentals, collapsing 51.84% over the past year and currently trading at ₹72.57, perilously close to its 52-week low of ₹71.99." }, { "title": "Lyka Labs Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/lyka-labs-ltd-is-rated-strong-sell-3803930", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LykaLabsLtd_mojoScore_3803930.png", "date": "2026-01-25 10:10:42", "description": "Lyka Labs Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 12 January 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 25 January 2026, providing investors with the latest perspective on the company’s position." }, { "title": "Lyka Labs Ltd Stock Falls to 52-Week Low of Rs 71.99", "link": "https://www.marketsmojo.com/news/stocks-in-action/lyka-labs-ltd-stock-falls-to-52-week-low-of-rs-7199-3798377", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LykaLabsLtd_priceRelatedfactors_3798377.png", "date": "2026-01-21 10:46:52", "description": "Lyka Labs Ltd’s shares declined to a fresh 52-week low of Rs.71.99 on 21 Jan 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical and biotechnology company’s stock has underperformed both its sector and the broader market, reflecting a series of financial setbacks and valuation pressures." } ], "total": 379, "sid": "189121", "stock_news_url": "https://www.marketsmojo.com/news/lyka-labs-189121" }, "announcements": [ { "caption": "Update On Scheme Of Amalgamation", "datetime": "02-Feb-2026", "details": "As per the letter attached", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "31-Jan-2026", "details": "As per the letter attached", "source": "BSE" }, { "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On 29Th January 2026", "datetime": "29-Jan-2026", "details": "As per letter attached", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Jan 27: Stock rises 1.63% to Rs.73.78 on moderate volume

Jan 28: Further gains of 2.18% to Rs.75.39 amid positive market momentum

Jan 29: Sharp decline of 3.74% to Rs.72.57 following Q2 FY26 results revealing sharp losses

Jan 30: Stock hits 52-week low at Rs.71.25, closing at Rs.71.43 (-1.57%)

Week Open

Rs.72.60

Read full news article

Lyka Labs Ltd Valuation Shifts Signal Heightened Risk Amidst Market Underperformance

2026-02-01 08:00:41

Lyka Labs Ltd has experienced a marked deterioration in its valuation parameters, shifting from fair to risky territory, as reflected in its sharply negative price-to-earnings (P/E) ratio and elevated price-to-book value (P/BV). This shift underscores growing investor concerns amid subdued financial performance and sector headwinds, prompting a downgrade to a Strong Sell rating by MarketsMOJO.

Read full news article

Lyka Labs Ltd Downgraded to Strong Sell as Quality Parameters Deteriorate

2026-02-01 08:00:14

Lyka Labs Ltd has seen a marked decline in its quality grading, slipping from an average to a below average rating as of 12 January 2026. This downgrade reflects deteriorating business fundamentals, including weakening profitability metrics, elevated debt levels, and inconsistent operational performance, raising concerns for investors amid a challenging market backdrop.

Read full news article

Are Lyka Labs Ltd latest results good or bad?

2026-01-30 19:18:04

Lyka Labs Ltd's latest financial results for Q2 FY26 reveal significant operational challenges. The company reported a net loss of ₹3.36 crores, a stark contrast to the profit of ₹0.93 crores in the previous quarter, indicating a troubling shift in profitability. Revenue for the quarter was ₹36.66 crores, reflecting a sequential increase of 10.99% from ₹33.03 crores in Q1 FY26, but this was accompanied by a year-on-year decline of 10.93% from ₹41.16 crores in Q2 FY25. The operating margin, which excludes other income, fell dramatically to -6.93%, down from 11.17% in the prior quarter. This substantial decline in margins suggests that the company is facing severe cost pressures, particularly with employee costs rising significantly, which have outpaced revenue growth. The profit before tax also turned negative, highlighting a critical profitability crisis. In terms of return metrics, the latest return on e...

Read full news article

Lyka Labs Ltd Stock Hits 52-Week Low Amid Continued Downtrend

2026-01-30 12:45:06

Lyka Labs Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a fresh 52-week low of Rs.71.25 today, marking a significant decline amid ongoing downward momentum. The stock has underperformed its sector and broader market indices, reflecting persistent pressures on its valuation and financial metrics.

Read full news article

Lyka Labs Q2 FY26: Sharp Losses Trigger Alarm as Operational Collapse Deepens

2026-01-29 19:15:44

Lyka Labs Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹264.00 crores, has plunged into severe operational distress in Q2 FY26, reporting a consolidated net loss of ₹3.36 crores compared to a profit of ₹0.93 crores in the previous quarter—a staggering decline of 461.29% quarter-on-quarter. Year-on-year, the loss represents a catastrophic 260.00% deterioration from the ₹2.10 crores profit reported in Q2 FY25. The stock has responded brutally to the company's deteriorating fundamentals, collapsing 51.84% over the past year and currently trading at ₹72.57, perilously close to its 52-week low of ₹71.99.

Read full news article

Lyka Labs Ltd is Rated Strong Sell

2026-01-25 10:10:42

Lyka Labs Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 12 January 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 25 January 2026, providing investors with the latest perspective on the company’s position.

Read full news article

Lyka Labs Ltd Stock Falls to 52-Week Low of Rs 71.99

2026-01-21 10:46:52

Lyka Labs Ltd’s shares declined to a fresh 52-week low of Rs.71.99 on 21 Jan 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical and biotechnology company’s stock has underperformed both its sector and the broader market, reflecting a series of financial setbacks and valuation pressures.

Read full news article